← Back to Clinical Trials
Recruiting NCT06399939

NCT06399939 The Function of Biphasic Sleep in Infants

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06399939
Status Recruiting
Phase
Sponsor University of Massachusetts, Amherst
Condition Sleep Deprivation
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2023-09-01
Primary Completion 2028-01-31

Trial Parameters

Condition Sleep Deprivation
Sponsor University of Massachusetts, Amherst
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 9 Months
Max Age 15 Months
Start Date 2023-09-01
Completion 2028-01-31
Interventions
NapWake

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study is designed to investigate developmental changes in naps and nap function on memory from 9 to 15 months of age. Memory is measured by a task in which the experimenter interacts with a toy and the measure of memory is whether the child imitates that action when given the toy. Sleep is assessed with a watch that detects motion which provides an estimate of sleep and a set of electrodes placed on the head that measures brain activity during sleep. Infants are recruited at 9 months and sleep and memory are measured again 3- and 6-months later. At each visit, memory is tested before and after a nap (either the morning or afternoon nap) and naps are recorded with the sleep electrodes.

Eligibility Criteria

Inclusion Criteria: 1. 9 months at the time of enrollment 2. normal birthweight (5.5 to 10 lbs) and gestational length (36-41 weeks) 3. must be willing and able to return for testing in 3 and 6 months (e.g., no plans to move out of the area) Exclusion Criteria: 1. born premature (\<36 weeks gestational age) 2. receiving services due to developmental delays 3. visual or motor disability 4. score \<85 on cognitive and language composite scales and/or \<80 on the average of the two composites of the Bayley Scales of Infant Development Fourth Edition (BSID-IV) administered at the first session. 5. Infants' motor development (gross and fine motor) will also be assessed using the BSID-IV, and an adjusted cutoff of 73 will be used to exclude infants with significant motor delays (given the motoric nature of the task). 6. traveling beyond 1 time zone within 2 weeks prior to testing (phone screening) 7. fever or symptoms of respiratory illness at the time of testing (phone screening) 8. physica

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology